Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-27 @ 11:53 PM
Study NCT ID:
NCT05483933
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2022-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
Sponsor:
Shattuck Labs, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-26
First Submit QC Date:
None
Study First Post Date:
2022-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-12-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED